A study has suggested that the current strategies aimed at changing perceptions towards measles, mumps and rubella vaccinations only serve to reinforce these false beliefs.
Browsing: Clinical > Vaccines
In this interview, we discuss public health and music playlists with Natasha Crowcroft, Chief of Applied Immunization Research and Evaluation at Public Health Ontario and Professor in Laboratory Medicine and Pathobiology and the Dalla Lana School of Public Health at the University of Toronto.
A chikungunya vaccine, developed by Themis Bioscience GmbH will be assessed for safety and efficacy in Phase II trials in Puerto Rico from August 2017.
Results from the early-stage APPROACH trial have demonstrated an investigational HIV vaccine regimen, based on mosaic vaccines, has been well-tolerated and immunogenic in healthy participants.
A new study has suggested that a small drop in the number of children vaccinated against measles in the US would lead to a disproportionately large number of cases.
Following a warning from the WHO about concerning antibiotic resistance in gonorrhoea, a vaccine originally developed for meningitis has shown promise for protecting against this disease.
A Phase I clinical trial has demonstrated that microneedle patches for flu vaccinations are safe, well-tolerated, immunogenic and also preferred by participants over intramuscular injection.
A live-attenuated Ebola vaccine has demonstrated promising results in a Phase I randomized controlled trial assessing safety and immunogenicity, according to a Canadian study.